QA: Achaogen Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001301501_2019_Achaogen_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001301501, Achaogen Inc

  xvar xval
0 AssetsCurrent 61,253,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,471,000
3 remainder_Assets 18,566,000
4 LiabilitiesCurrent 78,451,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 10,126,000
7 CostOfGoodsAndServicesSold 158
8 SellingGeneralAndAdministrativeExpense 218,557,419
9 ResearchAndDevelopmentExpense 112,681,715
10 remainder_Expenses 138,477,315
11 remainder_Revenues 9,499,800
12 remainder_NetIncome 4,425,705
13 remainder_ComprehensiveNetIncome 1,303
  yvar yval
0 Assets 82,290,000
1 Liabilities 88,577,000
2 Expenses 469,716,607
3 Revenues 9,499,800
4 StockholdersEquity -6,287,000
5 NetIncome -455,791,102
6 ComprehensiveNetIncome -455,790,450
7 BaseVar 327,255,208
8 EconomicCapitalRatiobeforeLimitedLiability -5.50
9 EconomicCapitalRatio 0.126

Edgar->Model Mapping

Feature Distribution

Change over Time